Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 2, 1998, Pages 362-369

  Svensson, J ^a   Lonn L ^a   Jansson, J O ^a   Murphy, G ^b   Wyss, D ^b   Krupa, D ^b   Cerchio, K ^b   Polvino, W ^b   Gertz, B ^b   Boseaus, I ^a   Sjostrom L ^a   Bengtsson, B A ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; GROWTH HORMONE DERIVATIVE; IBUTAMOREN; INSULIN; PLACEBO; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL METABOLIC RATE; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ENERGY EXPENDITURE; GASTRITIS; GLUCOSE HOMEOSTASIS; GROWTH HORMONE RELEASE; HUMAN; HYPERHIDROSIS; MALE; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; BASAL METABOLISM; BODY COMPOSITION; BODY CONSTITUTION; BODY MASS INDEX; DOUBLE-BLIND METHOD; ENERGY INTAKE; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; HUMAN GROWTH HORMONE; HUMANS; INDOLES; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OBESITY; PLACEBOS; PROLACTIN; SPIRO COMPOUNDS;

EID: 15644364105     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.2.362     Document Type: Article

References (47)

1. Bowers C, Momany F, Chang D, Hong A, Chang K. 1980 Structure-activity relationships of a synthetic pentapeptide that specifically releases GH in vitro. Endocrinology. 106:663-667.
2. Momany F, Bowers C, Reynolds G, Hong A, Newlander K. 1984 Conformational energy studies and in vitro activity data on active GH releasing peptides. Endocrinology. 114:1531-1536.
3. Bowers C, Sartor A, Reynolds G, Badger T. 1991 On the actions of the growth hormone-releasing hexapeptide, GHRP-6. Endocrinology. 128:2027-2035.
4. Korbonits M, Grossman A. 1995 Growth hormone-releasing peptide and its analogues. Novel stimuli to growth hormone release. Trends Endocrinol Metab. 6:43-49.
5. Ghigo E, Arvat E, Gianotti L, et al. 1944 Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. J Clin Endocrinol Metab. 78:693-698.
6. Smith R, Cheng K, Schoen W, et al. 1993 A non-peptidyl growth hormone secretagogue. Science. 260:1640-1643.
7. Copinschi G, Van Onderbergen A, L'Hermite-Balériaux M, et al. 1996 Effects of a 7-day treatment with a novel, orally active growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor-I, and adrenocortical function in normal young men. J Clin Endocrinol Metab. 81:2776-2782.
8. Chapman I, Bach M, Van Cauter E, et al. 1996 Stimulation of the growth hormone (GH)-insulin-like growth factor-I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab. 81:4249-4257.
9. Howard A, Feighner S, Cully D, et al. 1996 A pituitary gland and hypothalamic receptor that functions in growth hormone release. Science. 273:974-977.
10. Veldhuis J, Liem A, South S, et al. 1995 Differential impact of age, sex steroid hormones, and obesity on basal vs. pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab. 80:3209-3222.
11. Veldhuis J, Iranmanesh A, Ho K, Waters M, Johnson M, Lizzerade G. 1991 Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism in man. J Clin Endocrinol Metab. 72:51-59.
12. Cordido F, Penalva A, Dieguez C, Casanueva F. 1993 Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab. 76:819-823.
13. Reaven G. 1988 Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
14. Björntorp P. 1993 Visceral obesity: a "civilization syndrome". Obes Res. 1:206-222.
15. De Boer H, Blok G-J, Van Der Veen E. 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev. 16:63-86.
16. Rosén T, Bengtsson B-Å. 1990 Premature mortality due to cardiovascular diseases in hypopituitarism. Lancet. 336:285-288.
17. Markussis V, Beshyah S, Fisher C, Sharp P, Nicolaides A, Johnston D. 1992 Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 340:1188-1192.
18. Johannsson G, Mårin P, Lönn L, et al. 1997 Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab. 82:727-734.
19. Bruce Å, Andersson M, Arvidsson B, Isaksson B. 1980 Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age. Scand J Clin Lab Invest. 40:461-473.
20. Chowdbury B, Sjöström L, Alpsten M, Konstanty J, Kvist H, Löfgren R. 1994 A multicompartment body composition technique based on computed tomography. Int J Obes. 18:219-234.
21. Vartsky D, Elis K, Cohn S. 1979 In vivo quantification of body nitrogen by neutron capture prompt gamma-ray analysis. J Nucl Med. 20:1158-1165.
22. 252Cf source. J Radioanal Nucl Chem. 114:181-185.
23. Ferrannini E. 1988 The theoretical bases of indirect calorimetry: a review. Metabolism. 37:287-301.
24. Lindroos A-K, Lissner L, Sjöström L. 1993 Validity and reproducibility of a self-administered dietary questionnaire in obese and non-obese subjects. Eur J Clin Nutr. 47:461-481.
25. Li P, Lee J, MacGillivray M, Schaefer P, Siegel J. 1980 Direct, fixed-time kinetic assays for β-hydroxybuterate and acetoacetate with a central analyzer or a computer backed spectrophotometer. Clin Chem. 26:1713-1717.
26. Bowers C, Reynolds G, Durham D, Barrera C, Pezzoli S, Thorner M. 1990 Growth hormone (GH) releasing peptide stimulates GH release in normal men and acts synergistically with with GH releasing hormone. J Clin Endocrinol Metab. 70:975-982.
27. Gertz B, Barrett J, Eisenhandler R, et al. 1993 Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. J Clin Endocrinol Metab. 77:1393-1397.
28. Hartman M, Clayton P, Johnston M, et al. 1993 A low dose euglycemic infusion of recombinant insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest. 91:2453-2462.
29. Huhn W, Hartmann M, Pezzoli S, Thorner M. 1993 Twenty-four hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion, and specifically attenuates the response to a subsequent GHRP bolus. J Clin Endocrinol Metab. 76:1202-1208.
30. Jaffe C, Ho P, Demott-Friberg R, Bowers C, Barkan A. 1993 Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. J Clin Endocrinol Metab. 77:1641-1647.
31. Hickey G, Jacks T, Judith F, et al. 1994 Efficacy and specificity of L-692, 429, a novel nonpeptidyl growth hormone secretagogue, in beagles. Endocrinology. 134:695-701.
32. Lloyd R, Anagnostou D, Cano M, Barkan A, Chandler W. 1988 Analysis of mammosomatotropic cells in normal and neoplastic human pituitary tissues by the reverse hemolytic plaque assay and immunocytochemistry. J Clin Endocrinol Metab. 66:1103-1110.
33. Mårin P, Darin N, Amemeia T, Andersson B, Jern S, Björntorp P. 1992 Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism. 41:882-886.
34. Marcus R, Butterfield G, Holloway L, et al. 1990 Effects of short-term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab. 70:519-527.
35. Rudman D, Feller A, Nagraj H, et al. 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
36. Van Vliet G, Bosson D, Craen M, Du Caju M, Malvaux P, Vanderschueren-Lodeweyckx M. 1987 Comparative study of the lipolytic differences of pituitary-derived and biosynthetic human growth hormone in hypopituitary children. J Clin Endocrinol Metab. 65:876-879.
37. Johansson J-O, Oscarsson J, Bjarnason R, Bengtsson B-Å. 1996 Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF-binding proteins, and glucose homeostasis. Metabolism. 45:362-369.
38. Vaccarino F, Bloom F, Rivier J, Vale W, Koob G. 1985 Stimulation of food intake in rats by centrally administered hypothalamic growth hormone-releasing factor. Nature. 314:167-168.
39. Okada K, Ishii S, Minami S, Sugihara H, Shibasaki T, Wakabayashi I. 1996 Intraventricular administration of the growth hormone releasing peptide KP-102 increases food intake in free-feeding rats. Endocrinology. 137:5155-5158.
40. Dickson SL, Luckman SM. 1997 Induction of c-fos mRNA in NPY and GRF neurons in the rat arcleus nucleus following systemic injection of the growth hormone secretagogue, GHRF-6. Endocrinology. 138:771-777.
41. Clark JT, Kalra PS, Crowley WR, Kalra SP. 1984 Neuropeptide Y and human pancreatic polypeptide stimulate feeding in rats. Endocrinology. 115:427-429.
42. Caidahl K, Edén S, Bengtsson B-Ȧ. 1994 Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf). 40:393-400.
43. Stenlöf K, Johannsson G, Mårin P, Sjöström L, Bengtsson B-Ȧ. 1997 Energy expenditure in abdominally obese male subjects, effects of treatment with growth hormone [Abstract P-017]. Endocrinol Metab. 4(Suppl A):42.
44. Fowelin J, Attvall S, Lager I, et al. 1993 Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism. 42: 1443-1447.
45. DeFronzo R, Gunnarsson R, Björkman O, Olsson M, Wahren J. 1985 Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent diabetes mellitus. J Clin Invest. 76:149-155.
46. Lund S, Flyvberg A, Holman G, Larsen F, Pedersen O, Schmitz O. 1994 Comparative effects of IGF-I and insulin on the glucose transporter system in rat muscle. Am J Physiol. 267:E461-E466.
47. Ayling C, Moreland B, Zanelli J, Schulster D. 1989 Human growth hormone treatment of hypophysectomized rats increases the proportion of type-I fibres in skeletal muscle. J Endocrinol. 123:429-435.